Los Altos, CA, United States of America

Jeffrey S Loutit

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey S. Loutit

Introduction

Jeffrey S. Loutit is a notable inventor based in Los Altos, California. He has made significant contributions to the field of medicine, particularly in the treatment of bacterial infections. His innovative approach has the potential to improve the lives of many immunocompromised patients.

Latest Patents

Loutit holds a patent for "Methods of treating bacterial infections." This patent focuses on treating bacterial infections in immunocompromised subjects and those with underlying malignancies. The method involves administering a combination of meropenem and vaborbactam to suitable subjects, including those with a history of leukemia or lymphoma, organ transplants, or those receiving immunosuppressive medications. This innovative treatment could greatly benefit patients suffering from neutropenia or malignancies.

Career Highlights

Throughout his career, Loutit has worked with prominent companies in the pharmaceutical industry, including Melinta Subsidiary Corp. and Melinta Therapeutics, Inc. His work has been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Loutit has collaborated with esteemed colleagues such as Elizabeth Alexander and Michael N. Dudley. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective medical solutions.

Conclusion

Jeffrey S. Loutit's contributions to the field of medicine through his innovative patent and collaborations highlight his commitment to improving healthcare. His work continues to pave the way for advancements in treating bacterial infections in vulnerable populations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…